HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vivo serial assessment of aortic aneurysm formation in apolipoprotein E-deficient mice via MRI.

AbstractBACKGROUND:
Hyperlipidimic mice administered angiotensin II have been used for the study of abdominal aortic aneurysms (AAAs). The purpose of this study was to examine the use of MRI for studying AAA development and for examining the effects of pharmacological intervention on AAA development in the apolipoprotein E-deficient mouse.
METHODS AND RESULTS:
Suprarenal aortic aneurysms were generated in apolipoprotein E-deficient mice administered angiotensin II (1000 ng/kg per min) for up to 28 days. In vivo MRI was performed serially (once weekly) to assess AAA development and rupture. Comparison of AAA size as measured by in vivo and ex vivo MRI resulted in excellent agreement (r=0.96, P<0.0001). In addition, MRI correlated with histology-derived AAA area assessment (in vivo versus histology: r=0.84, P<0.0001; ex vivo versus histology: r=0.89, P<0.0001). In a separate study, angiotensin II-administered apolipoprotein E-deficient mice were treated with doxycycline (broad-based matrix metalloproteinase inhibitor; 30 mg/kg per day for 28 days). MRI was able to noninvasively assess a reduced rate of AAA development (46% versus 71%, P<0.05), a decreased AAA area (2.56 versus 4.02 mm(2), P<0.01), and decreased incidence of rupture (43% versus 100%) in treated versus control animals. Inhibition of aorta matrix metalloproteinase 2/9 activity was observed in the treated animals.
CONCLUSIONS:
These results demonstrate the use of MRI to noninvasively and temporally assess AAA development on pharmacological intervention in this preclinical cardiovascular disease model.
AuthorsGregory H Turner, Alan R Olzinski, Roberta E Bernard, Karpagam Aravindhan, Heather W Karr, Rosanna C Mirabile, Robert N Willette, Peter J Gough, Beat M Jucker
JournalCirculation. Cardiovascular imaging (Circ Cardiovasc Imaging) Vol. 1 Issue 3 Pg. 220-6 (Nov 2008) ISSN: 1942-0080 [Electronic] United States
PMID19808546 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoproteins E
  • Matrix Metalloproteinase Inhibitors
  • Angiotensin II
  • Matrix Metalloproteinases
  • Doxycycline
Topics
  • Angiotensin II (pharmacology)
  • Animals
  • Aorta, Abdominal (pathology)
  • Aortic Aneurysm, Abdominal (diagnosis, metabolism, pathology)
  • Apolipoproteins E (deficiency)
  • Doxycycline (pharmacology)
  • Magnetic Resonance Imaging
  • Male
  • Matrix Metalloproteinase Inhibitors
  • Matrix Metalloproteinases (metabolism)
  • Mice
  • Mice, Knockout

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: